
February 9, 2012: VentriPoint Installs First Updated VMS Heart Analysis System at Evelina Children's Hospital, London
January 18, 2012: Report on Meeting with FDA and Corporate Update
December 07, 2011: Benefits of VentriPoint's VMS System to be Presented at Prestigious Heart Conference
November 30, 2011: Nebraska Children's Hospital Joins Congenital Heart Disease Clinical Trial
November 1, 2011: VentriPoint Commences Clinical Studies of Pulmonary Arterial Hypertension Application Using VMS Heart Analysis System
October 20, 2011: Manchester Heart Centre in United Kingdom Obtains VMS Heart Analysis System
September 19, 2011: VentriPoint Launches Multicenter Clinical Trial for FDA Submission
August 29, 2011: VentriPoint Announces Appointment of New Chief Financial Officer
July 7, 2011: Dr. Robyn J. Barst to Lead Pulmonary Hypertension Clinical Development Program for Validation of VMS
June 29, 2011: St. Paul's Hospital Heart Centre in Vancouver Obtains VMS Heart Analysis System
June 10, 2011: VentriPoint Announces Closing of First Tranche of Unit Private Placement
June 7, 2011: Alberta Children's Hospital Obtains VentriPoint's VMS Heart Analysis System
May 18, 2011: VentriPoint to Exhibit at 45th Annual Meeting of Association of European Paediatric Cardiologists
May 17, 2011: Distinctive Shapes Found in Right Hearts of Patients with Pulmonary Arterial Hypertension Using 3D Shape Analysis
May 12, 2011: Riley Hospital for Children at Indiana University Health System is Fifth Installation of VMS
May 5, 2011: Noted Cleveland Clinic Cardiologist to Join VentriPoint Scientific Advisory Board
May 4, 2011: VentriPoint Announces Allocation of First 10 VMS Devices With Additional Shipments Planned in Response to Strong Demand,
Financial Results for Year Ended December 31, 2010
April 26, 2011: VentriPoint Appoints Dr. Robyn Barst to Scientific Advisory Board
April 21, 2011: Norwegian Cardiologists Use Breakthrough Technology to Study Heart Remodeling
April 04, 2011: Noted Oregon Cardiologists Conduct First Study on Adults using VentriPoint 3D Heart Analysis Technology
March 25, 2011: VentriPoint Announces Issuance of Shares for Debt Settlement
January 20, 2011: VentriPoint Announces Closing of Final Tranche of Unit Private Placement
January 10, 2011: VentriPoint Installs First VMS 3D Heart Analysis System in United States at Children's Hospital & Medical Center, Omaha
January 4, 2011: VentriPoint Receives US-FDA Response to 510k Submission for VMS Right Heart Analysis System
December 8, 2010: Prominent Canadian Cardiologist to Report Assessment of VentriPoint Heart Analysis System at International Medical Conference
November 29, 2010: VentriPoint Diagnostics Installs Cardiac Image Analysis System at the Rikshospitalet in Oslo, Norway
November 15, 2010: VentriPoint Diagnostics Appoints VP Sales & Business Development
November 8, 2010: VentriPoint Diagnostics Ltd. Retains the Howard Group for Investor Relations
October 28, 2010: VentriPoint Announces Appointment of Brad Harlow as Newest Member of its Board of Directors
October 6, 2010: VentriPoint Announces Closing of Private Placement
September 22, 2010: VentriPoint Announces Appointment of Dr. George Adams as President, CEO and Director
June 2, 2010: VentriPoint Announces Installation of Its VMS 3D Cardiac Technology in Toronto's Hospital
for Sick Children
February 1, 2010: VentriPoint Announces Proposed Private Placement
January 27, 2010: VentriPoint to Present Clinical Validation Study at American College of
Cardiology 59th Annual Scientific Session in March
January 20, 2010: VentriPoint Announces Acceptance of Second Clinical Validation Study for Publication
January 13, 2010: VentriPoint and Hospital For Sick Children Enter Into a MOU for Installation
of VentriPoint Medical System

VentriPoint Diagnostics Ltd. is a public Canadian company with its common shares traded on the TSX Venture Exchange under the symbol "VPT", its only operations being those of VentriPoint, Inc.
Complete and continuous disclosure documents, including audited financial statements can be found at: http://www.sedar.com/